Shire rises on Astrazenca bid talk: traders
LONDON (Reuters) - Shares in Shire (SHP.L) gained 2.3 percent in brisk volume on Wednesday, bucking a weaker European stock market, with traders citing rehashed talk of a potential bid from UK-listed pharmaceutical peer AstraZeneca (AZN.L).
Shire's stock had traded 70 percent of its full-day volume average at 1341 GMT and it was among the top risers on the pan-European FTSEurofirst 300 index .FTEU3, down 0.3 percent.
AstraZeneca said it did not comment on market rumours, while Shire was unavailable for comment.
(Written by David Brett; Editing by Francesco Canepa)
- Colorado baker discriminated by denying gay couple wedding cake: judge
- WTO overcomes last minute hitch to reach its first global trade deal
- Flights delayed as air pollution hits record in Shanghai
- Amish girl in Ohio will not be forced to resume chemo for cancer
- South Africa mourns Mandela, will bury him on December 15 |